Fetal trisomy 21 risk:Imp:Pt:Plas.cfDNA:Ord:Sequencing

Preferred Label : Fetal trisomy 21 risk:Imp:Pt:Plas.cfDNA:Ord:Sequencing;

LOINC status : ACTIVE;

LOINC display name : Trisomy 21 risk Sequencing Ql (cfDNA) [Interp];

LOINC long common name : Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative;

LOINC short name : Fet Ts 21 risk Plas.cfDNA Ql;

LOINC description : This term was created for, but is not limited in use to, Sequenom Laboratories' VisibiliT Trisomy 21 test, which analyzes circulating cell-free DNA extracted from maternal plasma using whole genome sequencing to determine the risk for fetal chromosome 21 aneuploidy. VisibiliT is indicated for use in pregnant women with average risk for fetal chromosomal aneuploidy.;

Détails

Origin ID

77014-9;

UMLS CUI

C4037270;

Has component
- Fetal trisomy 21 risk [LOINC component]
- Trisomy 21 [LOINC component]
- Trisomy 21 risk [LOINC component]
Has method
- Sequencing [LOINC method]
Has property
- Impression/interpretation of study [LOINC Property]
Has scale
- Ord [LOINC scale]
Has system
- Plasma [LOINC System]
- Plasma cell-free DNA [LOINC System]
- cell free DNA [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Noninvasive prenatal fetal 18 & 21 aneuploidy panel:-:Pt:Plas.cfDNA:-:Sequencing [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients